PortfoliosLab logo

Bellicum Pharmaceuticals, Inc. (BLCM)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Bellicum Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $17 for a total return of roughly -99.83%. All prices are adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%NovemberDecember2023FebruaryMarch
-66.67%
6.47%
BLCM (Bellicum Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BLCM

Bellicum Pharmaceuticals, Inc.

Return

Bellicum Pharmaceuticals, Inc. had a return of -44.44% year-to-date (YTD) and -77.01% in the last 12 months. Over the past 10 years, Bellicum Pharmaceuticals, Inc. had an annualized return of -54.01%, while the S&P 500 had an annualized return of 8.11%, indicating that Bellicum Pharmaceuticals, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-66.39%-5.31%
Year-To-Date-44.44%2.01%
6 months-70.37%0.39%
1 year-77.01%-10.12%
5 years (annualized)-65.34%7.32%
10 years (annualized)-54.01%8.11%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202358.33%-20.79%
2022-4.76%-11.67%-1.89%-30.77%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Bellicum Pharmaceuticals, Inc. Sharpe ratio is -0.74. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.00NovemberDecember2023FebruaryMarch
-0.74
-0.43
BLCM (Bellicum Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History


Bellicum Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-99.87%
-18.34%
BLCM (Bellicum Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Bellicum Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Bellicum Pharmaceuticals, Inc. is 99.87%, recorded on Mar 17, 2023. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.87%Jan 12, 20152060Mar 17, 2023
-19.93%Dec 19, 20143Dec 23, 20147Jan 5, 201510

Volatility Chart

Current Bellicum Pharmaceuticals, Inc. volatility is 377.76%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%NovemberDecember2023FebruaryMarch
377.76%
21.17%
BLCM (Bellicum Pharmaceuticals, Inc.)
Benchmark (^GSPC)